AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti

BSE733.8021.6 (+3.03 %)

PREV CLOSE (Rs.) 712.20

OPEN PRICE (Rs.) 718.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 66504

TODAY'S LOW / HIGH (Rs.)714.10 744.25

52 WK LOW / HIGH (Rs.)155.5 1025

NSE733.5021.2 (+2.98 %)

PREV CLOSE( Rs. ) 712.30

OPEN PRICE (Rs.) 714.00

BID PRICE (QTY) 733.50 (186)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1534378

TODAY'S LOW / HIGH(Rs.) 713.90 745.00

52 WK LOW / HIGH (Rs.)137.5 1026.95

More From Company Profile

Quarterly Results

Quarters

Select year

Particulars

Dec 2020

Sep 2020

Jun 2020

Mar 2020

Audited / UnAudited

UnAudited

Net Sales

5302.50

5781.10

5446.70

4496.40

Total Expenditure

4244.90

4616.70

4107.00

3783.30

PBIDT (Excl OI)

1057.60

1164.40

1339.70

713.10

Other Income

20.00

2.90

12.60

9.80

Operating Profit

1077.60

1167.30

1352.30

722.90

Interest

49.70

70.50

65.70

74.70

Exceptional Items

2.20

83.80

PBDT

1030.10

1096.80

1286.60

732.00

Depreciation

126.50

125.60

123.80

124.90

Profit Before Tax

903.60

971.20

1162.80

607.10

Tax

223.30

218.50

308.30

18.50

Provisions and contingencies

Profit After Tax

680.30

752.70

854.50

588.60

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

680.30

752.70

854.50

588.60

Minority Interest

0.05

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

680.30

752.75

854.50

588.60

Equity Capital

932.00

233.00

Face Value (IN RS)

10.00

Reserves

Calculated EPS

7.30

32.31

36.67

25.26

Calculated EPS (Annualised)

29.20

129.23

146.70

101.05

No of Public Share Holdings

37097200.00

9271800.00

9201284.00

8984757.00

% of Public Share Holdings

39.80

39.79

39.49

38.56

PBIDTM% (Excl OI)

19.95

20.14

24.60

15.86

PBIDTM%

20.32

20.19

24.83

16.08

PBDTM%

19.43

18.97

23.62

16.28

PBTM%

17.04

16.80

21.35

13.50

PATM%

12.83

13.02

15.69

13.09

Notes

ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.

CORPORATE OFFICE

address

9/2003-4,
Vishnu Priya Limda Chowk
Main Road
Surat – 395 003.

call us @ +91-261-6673500 +91-261-2436536

fax us @ +91-261-6673537

email us @ info@rwadiwala.com

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage.

AARTI DRUGS LTD.

Quarterly Results

Filing complaints on SCORES Easy & quick